Literature DB >> 16863565

Extracolonic cancers associated with hereditary nonpolyposis colorectal cancer in the Utah Population Database.

John Scott Maul1, Ned R Warner, Scott K Kuwada, Randall W Burt, Lisa A Cannon-Albright.   

Abstract

BACKGROUND: The data describing the extracolonic cancers associated with hereditary nonpolyposis colorectal cancer (HNPCC) are variable.
METHODS: We ascertained all Amsterdam I criteria-positive pedigrees (N = 18) in the Utah Population Database (UPDB). We identified the extracolonic cancers in the colorectal cancer cases (N = 65) in these pedigrees, and in their first- (N = 509) and second-degree (N = 1,611) relatives. Standardized morbidity ratios were estimated by comparing the observed rates of extracolonic cancer in defined sets of relatives of probands with population expected rates estimated internally from the UPDB.
RESULTS: The extracolonic cancers observed in significant excess in the 65 Amsterdam I criteria-positive colorectal cancer (CRC) cases in the UPDB were uterine (N = 3, p = 0.003), lip (N = 2, p = 0.007), stomach (N = 2, p = 0.009), female genitalia (N = 1, p = 0.004) and larynx (N = 1, p = 0.05). Extracolonic cancers observed in significant excess in the 509 first-degree relatives of the 65 colorectal cancer (CRC) cases in these Amsterdam I criteria pedigrees included: thyroid (N = 5, p = 0.0002) and prostate (N = 19, p = 0.002). Thyroid cancer (N = 6, p = 0.003) was found in significant excess in the second-degree relatives of the Amsterdam I criteria-positive CRC cases.
CONCLUSIONS: In this population-based examination of the extracolonic cancers at excess in classic HNPCC pedigrees (selected by Amsterdam I criteria) we not only observed many of the same cancers previously reported to be associated with HNPCC in both CRC probands and their relatives, but also identified several previously unreported associations. Although our sample size is small, this study is population based, lacks ascertainment and recall bias, and benefits from uniform, consistent diagnoses of all cancers in a statewide registry.

Entities:  

Mesh:

Year:  2006        PMID: 16863565     DOI: 10.1111/j.1572-0241.2006.00636.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  13 in total

1.  Cancer Risk in Families Fulfilling the Amsterdam Criteria for Lynch Syndrome.

Authors:  N Jewel Samadder; Ken Robert Smith; Jathine Wong; Alun Thomas; Heidi Hanson; Kenneth Boucher; Cathryn Kopituch; Lisa A Cannon-Albright; Randall W Burt; Karen Curtin
Journal:  JAMA Oncol       Date:  2017-12-01       Impact factor: 31.777

2.  Gastric cancers with microsatellite instability sharing clinical features, chemoresistance and germline MSH6 variants.

Authors:  Kentaro Yamashita; Yoshiaki Arimura; Mayuko Saito; Hiromu Suzuki; Tomohisa Furuhata; Koichi Hirata; Yasuhisa Shinomura
Journal:  Clin J Gastroenterol       Date:  2013-03-19

Review 3.  DNA mismatch repair and infertility.

Authors:  Sarmistha Mukherjee; Alex D Ridgeway; Dolores J Lamb
Journal:  Curr Opin Urol       Date:  2010-11       Impact factor: 2.309

4.  Elevated risk of prostate cancer among men with Lynch syndrome.

Authors:  Victoria M Raymond; Bhramar Mukherjee; Fei Wang; Shu-Chen Huang; Elena M Stoffel; Fay Kastrinos; Sapna Syngal; Kathleen A Cooney; Stephen B Gruber
Journal:  J Clin Oncol       Date:  2013-03-25       Impact factor: 44.544

5.  Population-based family history-specific risks for colorectal cancer: a constellation approach.

Authors:  David P Taylor; Randall W Burt; Marc S Williams; Peter J Haug; Lisa A Cannon-Albright
Journal:  Gastroenterology       Date:  2009-12-21       Impact factor: 22.682

6.  Population structure and inbreeding from pedigree analysis of purebred dogs.

Authors:  Federico C F Calboli; Jeff Sampson; Neale Fretwell; David J Balding
Journal:  Genetics       Date:  2008-05       Impact factor: 4.562

7.  Equivalent Helicobacter pylori infection rates in Lynch syndrome mutation carriers with and without a first-degree relative with gastric cancer.

Authors:  Eline C Soer; Laura W Leicher; Alexandra M J Langers; Paul C van de Meeberg; Egbert-Jan van der Wouden; Jan Jakob Koornstra; Marloes Bigirwamungu-Bargeman; Hans F A Vasen; Wouter H de Vos tot Nederveen Cappel
Journal:  Int J Colorectal Dis       Date:  2016-02-04       Impact factor: 2.571

8.  Multiple primary tumors following stage II and III rectal cancer in patients receiving radiotherapy, 1998-2010.

Authors:  Julie Smith-Gagen; George A Goodwin; Jonathan Tay
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-25       Impact factor: 4.553

9.  Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC).

Authors:  Johanne Geary; Peter Sasieni; Richard Houlston; Louise Izatt; Ros Eeles; Stewart J Payne; Samantha Fisher; Shirley V Hodgson
Journal:  Fam Cancer       Date:  2007-10-16       Impact factor: 2.375

10.  Evaluating the informatics for integrating biology and the bedside system for clinical research.

Authors:  Vikrant G Deshmukh; Stéphane M Meystre; Joyce A Mitchell
Journal:  BMC Med Res Methodol       Date:  2009-10-28       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.